Cite
Hino M, Matsuda K, Miyanaga A, et al. Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panel. Exp Ther Med. 2010;1(1):41-45doi: 10.3892/etm_00000007.
Hino, M., Matsuda, K., Miyanaga, A., Kuribayasi, H., Mizutani, H., Noro, R., Minegishi, Y., Okano, T., Seike, M., Kawakami, A., Yoshimura, A., Ogawa, N., Uesaka, H., Kudoh, S., & Gemma, A. (2010). Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panel. Experimental and therapeutic medicine, 1(1), 41-45. https://doi.org/10.3892/etm_00000007
Hino, Mitsunori, et al. "Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panel." Experimental and therapeutic medicine vol. 1,1 (2010): 41-45. doi: https://doi.org/10.3892/etm_00000007
Hino M, Matsuda K, Miyanaga A, Kuribayasi H, Mizutani H, Noro R, Minegishi Y, Okano T, Seike M, Kawakami A, Yoshimura A, Ogawa N, Uesaka H, Kudoh S, Gemma A. Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panel. Exp Ther Med. 2010 Jan;1(1):41-45. doi: 10.3892/etm_00000007. Epub 2010 Jan 01. PMID: 23136590; PMCID: PMC3490336.
Copy
Download .nbib